Android app on Google Play

Nabi Biopharmaceuticals (NABI) Reports Q3 Loss of $0.12

November 8, 2012 5:33 PM EST Send to a Friend
Get Alerts NABI Hot Sheet
Trade NABI Now!
Join SI Premium – FREE
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q3 EPS of ($0.12), versus ($0.07) reported last year. Revenue for the quarter came in at $632 thousand, versus $1.1 million reported last year.

For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment